124 related articles for article (PubMed ID: 20854269)
1. Reducing the multidimensionality of high-content screening into versatile powerful descriptors.
Gorenstein J; Zack B; Marszalek JR; Bagchi A; Subramaniam S; Carroll P; Elbi C
Biotechniques; 2010 Sep; 49(3):663-5. PubMed ID: 20854269
[TBL] [Abstract][Full Text] [Related]
2. Genetic interventions in mammalian cells; applications and uses in high-throughput screening and drug discovery.
Hampton SL; Kinnaird AI
Cell Biol Toxicol; 2010 Feb; 26(1):43-55. PubMed ID: 19904619
[TBL] [Abstract][Full Text] [Related]
3. Improving drug discovery with contextual assays and cellular systems analysis.
Westwick JK; Lamerdin JE
Methods Mol Biol; 2011; 756():61-73. PubMed ID: 21870220
[TBL] [Abstract][Full Text] [Related]
4. Impact of new technologies for cellular screening along the drug value chain.
Möller C; Slack M
Drug Discov Today; 2010 May; 15(9-10):384-90. PubMed ID: 20206290
[TBL] [Abstract][Full Text] [Related]
5. Development of a high-content screening assay panel to accelerate mechanism of action studies for oncology research.
Towne DL; Nicholl EE; Comess KM; Galasinski SC; Hajduk PJ; Abraham VC
J Biomol Screen; 2012 Sep; 17(8):1005-17. PubMed ID: 22706350
[TBL] [Abstract][Full Text] [Related]
6. Workflow-based software environment for large-scale biological experiments.
Kozak K; Bakos G; Hoff A; Bennett E; Dunican D; Davies A; Kelleher D; Long A; Csucs G
J Biomol Screen; 2010 Aug; 15(7):892-9. PubMed ID: 20625182
[TBL] [Abstract][Full Text] [Related]
7. A novel imaging-based high-throughput screening approach to anti-angiogenic drug discovery.
Evensen L; Micklem DR; Link W; Lorens JB
Cytometry A; 2010 Jan; 77(1):41-51. PubMed ID: 19834964
[TBL] [Abstract][Full Text] [Related]
8. Novel trends in high-throughput screening.
Mayr LM; Bojanic D
Curr Opin Pharmacol; 2009 Oct; 9(5):580-8. PubMed ID: 19775937
[TBL] [Abstract][Full Text] [Related]
9. Compound set enrichment: a novel approach to analysis of primary HTS data.
Varin T; Gubler H; Parker CN; Zhang JH; Raman P; Ertl P; Schuffenhauer A
J Chem Inf Model; 2010 Dec; 50(12):2067-78. PubMed ID: 21073183
[TBL] [Abstract][Full Text] [Related]
10. GPU accelerated support vector machines for mining high-throughput screening data.
Liao Q; Wang J; Webster Y; Watson IA
J Chem Inf Model; 2009 Dec; 49(12):2718-25. PubMed ID: 19961205
[TBL] [Abstract][Full Text] [Related]
11. Drug discovery: a view through the looking glass.
Lenhert S; Vellanti FG
Future Med Chem; 2012 Oct; 4(16):2011-3. PubMed ID: 23157232
[No Abstract] [Full Text] [Related]
12. Cheminformatics approaches to analyze diversity in compound screening libraries.
Akella LB; DeCaprio D
Curr Opin Chem Biol; 2010 Jun; 14(3):325-30. PubMed ID: 20457001
[TBL] [Abstract][Full Text] [Related]
13. [NMR in the fragment-based drug discovery].
Hanzawa H; Takizawa T
Tanpakushitsu Kakusan Koso; 2009 Sep; 54(12 Suppl):1617-21. PubMed ID: 21089597
[No Abstract] [Full Text] [Related]
14. [Practice of fragment-based lead discovery by X-rays].
Yamano A
Tanpakushitsu Kakusan Koso; 2009 Sep; 54(12 Suppl):1622-7. PubMed ID: 21089598
[No Abstract] [Full Text] [Related]
15. [Fragment-based lead discovery from smaller fragments to functional ligand].
Hatayama A; Habashita H
Tanpakushitsu Kakusan Koso; 2009 Sep; 54(12 Suppl):1611-6. PubMed ID: 21089596
[No Abstract] [Full Text] [Related]
16. RIP-CHIP in drug development.
Jain R; Doyle F; George AD; Kuentzel M; Frank D; Chittur SV; Tenenbaum SA
Methods Mol Biol; 2010; 632():159-71. PubMed ID: 20217577
[TBL] [Abstract][Full Text] [Related]
17. Multivariate dependence and genetic networks inference.
Margolin AA; Wang K; Califano A; Nemenman I
IET Syst Biol; 2010 Nov; 4(6):428-40. PubMed ID: 21073241
[TBL] [Abstract][Full Text] [Related]
18. High content screening: seeing is believing.
Zanella F; Lorens JB; Link W
Trends Biotechnol; 2010 May; 28(5):237-45. PubMed ID: 20346526
[TBL] [Abstract][Full Text] [Related]
19. A microarray-based approach for the identification of epigenetic biomarkers for the noninvasive diagnosis of fetal disease.
Chu T; Burke B; Bunce K; Surti U; Allen Hogge W; Peters DG
Prenat Diagn; 2009 Nov; 29(11):1020-30. PubMed ID: 19650061
[TBL] [Abstract][Full Text] [Related]
20. Hypothesis-driven screening.
Schopfer U; Engeloch C; Höhn F; Mees H; Leeds J; Glickman F; Scheel G; Ferrand S; Fekkes P; Pfeifer M
Methods Mol Biol; 2009; 575():297-316. PubMed ID: 19727621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
